This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (19)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

George W. Daneker, Jr, MD; Grant W. Carlson, MD; David C. Hohn, MD; Patrick Lynch, MD; Leor Roubein, MD; Bernard Levin, MD

Arch Surg. 1991;126(11):1348-1352.

Abstract
• Patients with obstructing cancers are ineligible for preoperative chemotherapy and radiation unless they undergo surgical diversion. Endoscopic laser therapy (ELT) may provide an alternative to colostomy for these patients. We retrospectively reviewed all patients with distal sigmoid and rectal carcinomas who underwent ELT from January 1988 through April 1990. The majority of patients were referred for palliation of advanced disease. Thirty-seven patients underwent 123 ELT sessions (median, 2.5; range, one to 18). In 84% of patients, patency was maintained during a median follow-up of 31.5 weeks (range, one to 123). Morbidity and mortality were 2.5% (3/123) and 5% (1/37), respectively. Sixty-two percent had radiotherapy, chemotherapy, and/or surgery concurrent with ELT. Endoscopic laser therapy can safely and effectively reestablish and maintain luminal patency in patients with obstructing distal cancers. In addition, ELT can enable the administration of preoperative adjuvant radiotherapy and chemotherapy.

(Arch Surg. 1991;126:1348-1352)

Author Affiliations
From The University of Texas M. D. Anderson Cancer Center, Houston.

Footnotes
Accepted for publication August 17, 1991.

Presented at the 44th Annual Cancer Symposium of the Society of Surgical Oncology, Orlando, Fla, March 25, 1991.

Reprint requests to The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 106, Houston, TX 77030.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?